Epidemiological studies suggest that certain micronutrients may improve or maintain cognitive function. Consistent demonstration of benefits in intervention trials has been elusive, possibly because most intervention trials do not select subjects on the basis of nutrient status and/or intake. The objective of this review was to identify levels of intake or markers of nutrient insufficiency that define at-risk older adult populations to determine whether these populations will benefit from nutritional intervention. This review examines evidence from interventional and prospective observational studies that evaluated the effects of folate, vitamin B12, and vitamin E on cognitive decline in older populations. The studies suggest that supplementation may protect against cognitive decline when serum folate is <12nmol/L or vitamin E intake is <6.1mg/day. The literature is inadequate to define a level for vitamin B12. Epidemiological studies investigating the relations of nutrients to cognitive decline should consider nutrient status in the reporting and interpretation of results. Randomized trials should design inclusion and exclusion criteria to select individuals with low intake and to disallow multivitamin intake. These recommendations may be useful for the design of valid trials and to advance the current understanding of nutrition and neurological diseases.
CITATION STYLE
Barnes, J. L., Tian, M., Edens, N. K., & Morris, M. C. (2014). Consideration of nutrient levels in studies of cognitive decline. Nutrition Reviews, 72(11), 707–719. https://doi.org/10.1111/nure.12144
Mendeley helps you to discover research relevant for your work.